Chlorhexidine Gluconate Wipes Market Summary
As per MRFR Analysis, the Global Chlorhexidine Gluconate Wipes Market was valued at USD 0.1 Billion in 2022 and is projected to reach USD 0.15 Billion by 2032, growing at a CAGR of 4.78% from 2023 to 2032. The market is driven by rising infection-prevention awareness and the increasing prevalence of hospital-acquired infections (HAIs). Chlorhexidine gluconate wipes are widely used in healthcare settings to reduce HAIs and are gaining traction in personal hygiene due to the COVID-19 pandemic. The demand for these wipes is also bolstered by their application in dental clinics and the growing focus on infection control measures.
Key Market Trends & Highlights
The market is witnessing significant growth due to various factors.
- Market Size in 2022: USD 0.1 Billion; projected to reach USD 0.15 Billion by 2032.
- CAGR of 4.78% during the forecast period (2023 - 2032).
- Rising prevalence of hospital-acquired infections (HAIs) is propelling market growth.
- Increasing demand for personal hygiene products due to COVID-19.
Market Size & Forecast
2022 Market Size: USD 0.1 Billion
2023 Market Size: USD 0.11 Billion
2032 Market Size: USD 0.15 Billion
CAGR: 4.78% (2023 - 2032)
Largest Regional Market: North America.
Major Players
Key players include GAMA Healthcare Ltd (UK), Carenow Medical Pvt. Ltd. (India), PDI Limited (US), Lernapharm Inc. (Canada), Pal International (UK), Becton Dickinson and Company (US), 3M (US), and Cardinal Health (US).
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Chlorhexidine Gluconate Wipes Market Trends
- The rising prevalence of hospital-acquired infections (HAIs) is propelling market growth.
Market CAGR for chlorhexidine gluconate wipes is being driven by the increasing prevalence of hospital-acquired infections (HAIs). Hospital-acquired infections (HAIs) are infections that individuals get while staying in hospitals or other healthcare facilities. These diseases are caused by bacteria, viruses, and other microbes found in the hospital environment. HAIs are a big worry for healthcare practitioners because they can result in prolonged hospital admissions, increased healthcare expenses, and even mortality in severe situations. Chlorhexidine gluconate wipes are commonly used in hospitals and other healthcare institutions to reduce the spread of HAIs. Chlorhexidine gluconate is a broad-spectrum antiseptic that is effective against a wide variety of bacteria. Chlorhexidine gluconate wipes are used to disinfect the skin of patients before surgery and other medical operations, as well as the surfaces of medical equipment and other hospital objects.
The rising occurrence of HAIs is propelling the chlorhexidine gluconate wipes market forward. Every year, hundreds of millions of patients worldwide are affected by HAIs, resulting in severe morbidity and mortality, according to the World Health Organization (WHO). The growing awareness of the necessity of infection prevention and control in hospitals and other healthcare settings is driving demand for chlorhexidine gluconate wipes. Furthermore, the growing use of chlorhexidine gluconate wipes in emerging countries is propelling the market forward. Market participants are extensively spending in R&D operations to create enhanced chlorhexidine gluconate wipes that can give better protection against HAIs. As a result, the rising prevalence of HAIs, as well as increased awareness about infection prevention and control in hospitals and other healthcare facilities, are driving the chlorhexidine gluconate wipes market.
Moreover, the COVID-19 epidemic has increased demand for personal hygiene goods like sanitizers, disinfectants, and wipes. To prevent the spread of COVID-19, chlorhexidine gluconate wipes are extensively used as a disinfectant. Demand for chlorhexidine gluconate wipes is being driven by rising awareness of the importance of personal cleanliness and the need to avoid the spread of infectious diseases. Furthermore, the growing use of chlorhexidine gluconate wipes in homes and public places such as airports, shopping malls, and offices is propelling the market forward. The COVID-19 pandemic has also boosted hospital admissions, increasing the demand for chlorhexidine gluconate wipes. To reduce the spread of COVID-19 among patients and healthcare staff, hospitals and other healthcare institutions are employing chlorhexidine gluconate wipes. Market participants are significantly spending in R&D to create enhanced chlorhexidine gluconate wipes that can provide better protection against COVID-19 and other infectious diseases. As a result, increased demand for personal hygiene products as a result of the COVID-19 pandemic is another factor propelling the chlorhexidine gluconate wipes market forward.
In addition, chlorhexidine gluconate wipes are commonly used in dental clinics to minimize infection transmission during dental operations. Infections can occur during dental treatments such as root canal therapy, tooth extraction, and implant implantation if suitable infection control measures are not implemented. Chlorhexidine gluconate wipes are used in dental clinics to clean the surfaces of dental equipment and other things. Furthermore, chlorhexidine gluconate wipes are used to disinfect the oral cavity prior to and following dental treatments.
The growing demand for dental operations as a result of the increased frequency of dental problems is propelling the chlorhexidine gluconate wipes market forward. Dental problems, according to the World Health Organization (WHO), affect billions of people ly, causing significant morbidity and mortality.
Chlorhexidine Gluconate Wipes Market Segment Insights
Chlorhexidine Gluconate Wipes Product Type Insights
The Chlorhexidine Gluconate Wipes Market segmentation, based on Product Type includes CHG Bath Wipes, CHG/Alcohol-Based Wipes. The CHG bath wipes category has one of the greatest market shares. CHG bath wipes are used to clean the skin before to surgical procedures and are also used to bathe patients in hospitals and other healthcare settings on a daily basis. The growing demand for CHG bath wipes in hospitals and other healthcare settings is propelling this industry forward. Furthermore, the rising prevalence of hospital-acquired diseases and the necessity to minimize infection spread in healthcare settings are boosting demand for CHG bath wipes.
Chlorhexidine Gluconate Wipes Concentration Insights
The Chlorhexidine Gluconate Wipes Market segmentation, based on Concentration, includes 2%, 5%. The 5% catgeory is one of the fastest-growing areas in the chlorhexidine gluconate wipes industry. The 5% concentration CHG wipes are used for skin antisepsis, and their popularity is growing due to their efficiency in reducing surgical site infections and catheter-related bloodstream infections. The rising occurrence of surgical site infections, as well as the necessity to minimize hospital-acquired infections, is driving the demand for 5% concentration CHG wipes.
Figure1: Chlorhexidine Gluconate Wipes Market, by Concentration, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
hlorhexidine Gluconate Wipes Application Insights
The Chlorhexidine Gluconate Wipes Market segmentation, based on application, includes surgical site infection, central line-associated bloodstream infection, catheter-associated urinary tract infections, lens cleaners. Catheter-associated urinary tract infections category is one of the highest market share segments in the chlorhexidine gluconate wipes industry. CAUTI is a prevalent healthcare-associated illness caused by the use of urinary catheters. CHG wipes are excellent at preventing CAUTI and are frequently used in hospitals and other healthcare settings. The rising prevalence of CAUTI and the necessity to limit infection spread in healthcare settings are driving the demand for CHG wipes for CAUTI prevention. As a result, the CAUTI sector is projected to continue to dominate the chlorhexidine gluconate wipes market in the future years.
Chlorhexidine Gluconate Wipes Distribution Channel Insights
The Chlorhexidine Gluconate Wipes Market segmentation, based on distribution channel, includes hospital & retail pharmacies, online platforms. The hospital & retail pharmacies category has the highest market share in the chlorhexidine gluconate wipes market. The growing demand for CHG wipes in hospitals and other healthcare settings is propelling the expansion of this market. Furthermore, the rising prevalence of hospital-acquired illnesses, as well as the necessity to prevent the transmission of diseases in healthcare settings, are boosting demand for CHG wipes. Retail pharmacies are also contributing to the expansion of this industry by offering CHG wipes for personal use.
Chlorhexidine Gluconate Wipes Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America dominates the chlorhexidine gluconate wipes market, due to the increasing prevalence of hospital-acquired infections and the growing knowledge regarding the use of CHG wipes for infection prevention. The high healthcare expenditure in North America, as well as the availability of advanced healthcare facilities, are also contributing to the growth of the market in this region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure2: CHLORHEXIDINE GLUCONATE WIPES MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Chlorhexidine Gluconate Wipes Market accounts for the second-largest market share due to the increasing prevalence of hospital-acquired infections and the growing knowledge regarding the use of CHG wipes for infection prevention. Further, the German Chlorhexidine Gluconate Wipes Marketheld the largest market share, and the UK Chlorhexidine Gluconate Wipes Market was the fastest growing market in the European region
The Asia-Pacific Chlorhexidine Gluconate Wipes Marketis expected to grow at the fastest CAGR from 2023 to 2032. This is due to the increasing prevalence of hospital-acquired infections and the growing knowledge regarding the use of CHG wipes for infection prevention. Moreover, China’s Chlorhexidine Gluconate Wipes Market held the largest market share, and the Indian Chlorhexidine Gluconate Wipes Market was the fastest growing market in the Asia-Pacific region.
Chlorhexidine Gluconate WipesKey Market Players& Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Chlorhexidine Gluconate Wipes Market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Chlorhexidine Gluconate Wipesindustry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Chlorhexidine Gluconate Wipes industry to benefit clients and increase the market sector. In recent years, the Chlorhexidine Gluconate Wipes industry has offered some of the most significant advantages to medicine. Major players in the Chlorhexidine Gluconate Wipes Market, including GAMA Healthcare Ltd (UK), Carenow Medical Pvt. Ltd. (India), PDI Limited (US), Lernapharm Inc. (Canada), Pal International (UK) and others, are attempting to increase market demand by investing in research and development operations.
The Clorox Company is a manufacturer and marketer of consumer and professional goods based in the United States. The Oakland, California-based corporation employed roughly 8,800 employees worldwide as of 2020. Net sales for the fiscal year 2020 were $6.7 billion. Clorox was ranked 474th on Fortune magazine's 2020 Fortune 500 list, which has been published annually since 2000. In 2021, Clorox Healthcare has introduced a new brand of disinfection wipes that are resistant to the SARS-CoV-2 virus. The wipes are intended for usage in healthcare settings and have a kill time of 30 seconds.
Reckitt Benckiser Group plc, doing business as Reckitt, is a British multinational consumer goods corporation based in Slough, England. It manufactures health, hygiene, and nutrition products. Reckitt & Colman plc of the United Kingdom and Benckiser N.V. of the Netherlands merged to form the company. In 2020, Lysol's parent business, Reckitt Benckiser Group plc, announced that Lysol disinfection wipes and sprays are effective against the SARS-CoV-2 virus. The company has introduced a new range of disinfectant wipes developed specifically to eliminate the virus.
Key Companies in the Chlorhexidine Gluconate Wipes market include
Chlorhexidine Gluconate WipesIndustry Developments
In April 2021, 3M has released a novel disinfection wipe that kills the SARS-CoV-2 virus in 15 seconds.
In March 2020, Nice-Pak Products, Inc. subsidiary PDI Healthcare has introduced a new line of alcohol-free disinfectant wipes that are effective against a wide range of diseases, including the SARS-CoV-2 virus.
In February 2019, Ecolab Inc. has introduced a new brand of disinfection wipes that can kill germs in 30 seconds or less. The wipes are effective against a wide variety of infections, including SARS-CoV-2.
Chlorhexidine Gluconate Wipes Market Segmentation
Chlorhexidine Gluconate Wipes Market By Product Type Outlook
Chlorhexidine Gluconate Wipes Market By Concentration Outlook
Chlorhexidine Gluconate Wipes Market By Application Outlook
Chlorhexidine Gluconate Wipes Market By Distribution Channel Outlook
Chlorhexidine Gluconate Wipes Regional Outlook
| Report Attribute/Metric |
Details |
| Market Size2022 |
USD 0.1Billion |
| Market Size 2023 |
USD 0.11Billion |
| Market Size2032 |
USD 0.15 Billion |
| Compound Annual Growth Rate (CAGR) |
4.78% (2023-2032) |
| Base Year |
2022 |
| Market Forecast Period |
2023-2032 |
| Historical Data |
2018- 2022 |
| Market Forecast Units |
Value (USD Billion) |
| Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
Product Type, Concentration, Application, Distribution Channel and Region |
| Geographies Covered |
North America, Europe, AsiaPacific, and the Rest of the World |
| Countries Covered |
The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled |
Becton, Dickinson and Company (US), 3M (US), Cardinal Health (US), GAMA Healthcare Ltd (UK), Carenow Medical Pvt. Ltd. (India), PDI Limited (US), Lernapharm Inc. (Canada), Pal International (UK) and others. |
| Key Market Opportunities |
The development of CHG wipes, as well as the presence of a large patient population, as well as investment by industry players |
| Key Market Dynamics |
Infections at surgical sites are becoming more common. |
Chlorhexidine Gluconate Wipes Market Highlights:
Frequently Asked Questions (FAQ) :
The Chlorhexidine Gluconate Wipes Market size was valued at USD 0.1Billion in 2022.
The market is projected to grow at a CAGR of 4.78% during the forecast period, 2023-2032.
North America had the largest share in the market
The key players in the market are GAMA Healthcare Ltd (UK), Carenow Medical Pvt. Ltd. (India), PDI Limited (US), Lernapharm Inc. (Canada), Pal International (UK).
The 5% category dominated the market in 2022.
The CHG bath wipes had the largest share in the market.
